Filing Details

Accession Number:
0000899243-23-009990
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-29 17:51:32
Reporting Period:
2023-03-27
Accepted Time:
2023-03-29 17:51:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1610676 Anne Mary Heino C/O Lantheus Holdings, Inc.
201 Burlington Road, South Bldg
Bedford MA 01730
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-27 44,484 $19.11 463,881 No 4 M Indirect Common Stock
Common Stock Disposition 2023-03-27 28,662 $80.47 435,219 No 4 S Indirect Common Stock
Common Stock Disposition 2023-03-27 15,822 $81.30 419,397 No 4 S Indirect Common Stock
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect Common Stock
No 4 S Indirect Common Stock
No 4 S Indirect Common Stock
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2023-03-27 44,484 $0.00 44,484 $19.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-04-15 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 300,000 Indirect By Grantor Retained Annuity Trust
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023.
  2. On March 10, 2023, the reporting person transferred 300,000 shares of LNTH common stock to a Grantor Retained Annuity Trust of which the reporting person's spouse is a trustee. The reporting person and members of her immediate family are the sole beneficiaries of the trust.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.89 to $80.88, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.89 to $81.838, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. 100% of the shares subject to the option are fully vested and exercisable.